Key result
In vitro exposure to desflurane significantly reduced platelet aggregation response to ADP (37.5-73.3% of control) and collagen (77.1-79.8% of control) similarly to halothane.
Why the study?
Does desflurane inhibit platelet function in vitro similarly to halothane?
Does desflurane inhibit platelet function in vitro similarly to halothane?
Desflurane impairs platelet aggregation in vitro similarly to halothane, likely via impairment of thromboxane receptor signaling, without affecting alpha-degranulation.
Answers are grounded in this paper and cite their sources.
Requires clinical evaluation for perioperative bleeding risk; leaves open whether desflurane affects hemostasis in vivo.
Background and objective: The effects of the volatile anaesthetic desflurane on platelet activation in vitro were studied and compared to those of halothane. Methods: Platelet-rich plasma was exposed to 2 MAC of desflurane or halothane, or air only and stimulated by platelet agonists ADP (2.5, 5 and 10 μmol L−1) and collagen (10 μg mL−1). Platelet response was measured by Born aggregometry (maximum aggregation response, area under the curve) and flow cytometry (mean channel fluorescence, percentage of CD62P-positive cells, index of platelet activation for positive platelets). Results: Aggregation response was significantly reduced in platelets exposed to desflurane or halothane; the inhibitory effect was more pronounced when the areas under the curve were analysed: values ranged from 37.5% to 73.3% of control samples for ADP stimulation and 77.1% to 79.8% for collagen stimulation. CD62P expression before and after stimulation with receptor agonists was not statistically different in platelets exposed to desflurane, halothane or air. Conclusions: By impairing platelet aggregation while not affecting α-degranulation desflurane has a differential effect on various aspects of platelet activation similar to halothane. Our results are compatible with the hypothesis of an impairment of platelet thromboxane receptor signalling by halothane. We suggest a similar mechanism for desflurane.
No takes yet. Share an insight, caveat, or question.
Berlet et al. (2003) studied this question. Desflurane vs. Halothane or air only was evaluated on Platelet aggregation response and CD62P expression. In vitro exposure to desflurane significantly reduced platelet aggregation response to ADP (37.5-73.3% of control) and collagen (77.1-79.8% of control) similarly to halothane.
Synapse has enriched 10 related papers. Consider them for comparative context: